A GlobalFoundries Director Sold Ahead of Earnings. Here's What Long-Term Investors Should Know This insider sale follows a volatile stretch for the stock, which is nonetheless up about 40% this past year.
What Nvidia Could Be Worth on a $1,000 Investment if History Repeats Itself Nvidia could still deliver impressive gains if Wall Street keeps raising its earnings estimates.
Why Billionaire Stanley Druckenmiller and Wall Street Analysts Love This Biotech Stock The company is on the verge of becoming a commercial-stage biotech, with two promising therapies in phase 3 trials.
An IQVIA Insider Just Sold Over $1 Million in Stock. Here's What Long-Term Investors Should Know Sherbet's disposition leaves him with 20,999 directly held shares valued at $5.2 million as IQVIA trades near $238.
An IQVIA CEO Sold $26.1 Million as Bookings Hit a Record $3.15 Billion Bousbib exercised expiring stock appreciation rights while maintaining about 1.4 million shares in total beneficial ownership.
Is Arm Holdings Stock a Buy on the Bullish CPU Outlook? The company is now more confident in hitting its near-term CPU target.
AstraZeneca, Bristol Myers Squibb Reportedly in Talks for $400 Billion Merger AstraZeneca in talks to merge with Bristol Myers Squibb, creating $400B pharma giant, while talks ongoing for months, antitrust scrutiny is expected.
The Advantages of Electricity-Free Coolant Recycling Equipment Efficient coolant management is essential for maintaining high-performance machining operations. Clean coolant helps reduce heat, lubricate cutting tools,
3 Dividend Stocks That Are No-Brainer Buys for the Second Half of 2026 As stocks pull back from recent highs, lean into these three blue chip dividend stocks.
Years of Bad Financial Decisions Left Me With $145K in Debt. I Don't Know Where to Start Years of bad financial decisions left one person with about $145,000 in debt, despite earning a six-figure salary. Now, after years of trying to stay on top of mounting payments, they’re emotionally drained, overwhelmed
Why This Business First Insider Sale Matters Less Than Second-Half Loan Growth And Deposits Keith Mansfield's transaction reduced his direct equity stake by 5%, though he retains 77,139 shares and 13,374 restricted stock units vesting through 2029.
Un viculu ciecu suciale. À quelli chì sò cuncernati.U sughjettu: Burocrazia distruttiva.Care Signore/Care Signore.Sò un omu di 53 anni chì stà in u quartieru Kiryat Menachem di Ghj
ARK Innovation ETF Sell-Off Deepens as Outflows Accelerate The ARKK ETF continued its sell-off last week as investors continued dumping Cathie Wood's flagship fund amid substantial concerns.
What This Business First Insider Sale Signals After a 34% Stock Run George W. Iii Cummings reduced his stake by 8% while the stock posted a 34% one-year return, leaving him with ~225,000 shares and a 0.69% ownership position.
I’m 54 With $1.5M Saved and Feel Rich but the Thought of Spending It Makes Me Sick. Can I Still Retire Early? Saving enough for retirement is supposed to bring peace of mind. For some people, though, reaching that milestone creates a different kind of anxiety. After spending decades watching a portfolio grow, the idea of seeing
Aehr Test Systems vs. C3.ai: Which Technology Stock Is a Better Buy in 2026? Both companies are burning cash and trading at steep multiples, but their paths to profitability, and their risks, couldn't be more different.
Stock Market This Week: Top Three Catalysts for S&P 500 and Dow Jones These are the top stock market news to watch this week that will move the Dow Jones and S&P 500 indices, including earnings.
IonQ vs. Rigetti: Which Quantum Computing Stock Is a Better Buy in 2026? IonQ is scaling with 201% revenue growth and a domestic semiconductor play, while Rigetti faces revenue headwinds and capital constraints.
Palantir Stock Cheapest It Has Been in Three Years as Earnings Loom Palantir stock has dropped substantially this year, with several valuation metrics showing that it is highly undervalued as earnings loom.
